shouldiuse.io

Categories

VERDICT

Should I use medRxiv?

The preprint server for Health Sciences - medrxiv.org

Worth it. Free and field-standard for health researchers sharing unreviewed findings before journal publication. Not for patients or anyone needing peer-reviewed, citable evidence.

Confidence

Medium. Based on 50+ public sources; many snippets truncated and no verbatim user quotes extractable.

Ratings

  • Value for money
  • Ease of use
  • Feature depth
  • Support qualityNo evidence in sources.
  • Security posture

Pricing

$0

Free

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed
Free tierYes

Best for

  • Clinical and public-health researchers
  • Authors sharing findings before journal review
  • Evidence watchers needing API/TDM access
  • Medical educators tracking emerging work

Not for

  • Patients seeking medical advice
  • Teams needing peer-reviewed, citable evidence
  • Non-health research (use bioRxiv or arXiv)
  • Anyone expecting curated, vetted content

Gotchas - check before you buy

high

Preprints here are not peer-reviewed — never treat them as final evidence.

medium

Site has gone down before (Cloudflare issue); expect occasional downtime.

low

FAQ raises submission charges but the answer wasn't visible — verify before submitting.

low

Domain appears in 291 infostealer credential logs — user-side exposure, not a server breach.

Pros and cons

Pros

  • Free to read, with free machine/text-and-data-mining access
  • De facto preprint server for health sciences research
  • Nonprofit-run, backed by $2M Chan Zuckerberg grant
  • Submissions screened before posting
  • Frontiers integration enables direct journal transfer

Cons

  • Not peer-reviewed; screening only
  • Citation reliability of preprints questioned in published research
  • Extended outage tied to Cloudflare issue reported
  • Unvetted findings can mislead clinical readers

Sources & method

Analyzed 9/24/2026 - 14 sources - No known vulnerabilities found in the sources reviewed.

official x4review x3security x2news x5

Key stats

  • Value for money: 5/5

    Rating

  • $0

    Starting price

  • 14

    Sources

  • Analyzed

  • Value for money: 5/5. Completely free, including machine access.
  • Ease of use: 4/5. Simple submission; screening adds wait time.
  • Feature depth: 4/5. Collections, APIs, review articles; no peer review.
  • Support quality. No evidence in sources.
  • Security posture: 4/5. No known vulnerabilities; one outage reported.
  • 2019 Founded Launched by Cold Spring Harbor Laboratory
  • Free Price Reading, submissions, and API/TDM access
  • $2M CZI funding Chan Zuckerberg Initiative grant
  • openRxiv Operated by Newly formed nonprofit

Pricing

Free

$0

  • Read all preprints
  • Submit screened manuscripts
  • Free API and TDM access

Security

No known vulnerabilities found in the sources reviewed.

What users say

Researchers treat medRxiv as the go-to venue for early clinical findings, while clinicians and readers debate how much preprint results can be trusted.

Full analysis

Based on 50+ public sources; many snippets truncated and no verbatim user quotes extractable.

Free nonprofit preprint server for health sciences — great for researchers posting early findings; not peer-reviewed, not for patients.

Methodology

Based on 50+ public sources; many snippets truncated and no verbatim user quotes extractable.

Sources

  1. official
  2. medRxiv FAQmedrxiv.org
    official
  3. official
  4. official
  5. review
  6. review
  7. review
  8. news
  9. news
  10. news
  11. news
  12. security
  13. security
  14. medRxiv - Wikipediaen.wikipedia.org
    news

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.